Cubist Pharmaceuticals Price Target Raised to $70.00 at UBS AG (CBST)

Publish date: Wed, 31 Jul 2013, 10:32 PM

Investment analysts at UBS AG hoisted their price objective on shares of Cubist Pharmaceuticals (NASDAQ:CBST) from $61.00 to $70.00 in a note issued to investors on Wednesday, AnalystRatingsNetwork reports. The firm currently has a “buy” rating on the stock. UBS AG’s price target suggests a potential upside of 12.31% from the stock’s previous close.

Discussions
Be the first to like this. Showing 1 of 1 comments

henhill69

Check out the details of CBST's Planned Acquisitions of OPTR & TSRX @ http://stks.co/adA3

2013-08-02 12:46

Post a Comment